Cboe Global Markets has received regulatory approval from the Australian Securities & Investments Commission to operate a stock listings market in Australia, enabling it to compete directly with ASX Ltd. for initial public offerings. This milestone advances Cboe’s international expansion and is expected to increase choices for Australian investors while challenging the dominance of the country’s primary exchange. We'll explore how Cboe's entry into Australian stock listings could impact its growth outlook and global exchange industry position.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 35 best rare earth metal stocks of the very few that mine this essential strategic resource.

Cboe Global Markets Investment Narrative Recap

To own Cboe Global Markets, you need to believe in the long-term growth of global electronic trading, diversification across geographies and products, and the company's ability to expand internationally while defending its core index options business. The recent Australian regulatory approval is a meaningful step for global expansion, but it does not materially shift the near-term catalyst, which remains trading volumes and index options renewal risk.

One recent company announcement of interest is Cboe's planned launch of Cboe Continuous futures, including bitcoin and ether contracts, on its U.S. exchange in November. While new products can broaden recurring revenue, derivatives trading volumes and progress in key overseas markets continue to be the areas most closely watched by investors as potential growth drivers.

By contrast, investors should also be mindful of concentration risk if the S&P index options partnership terms change or fail to renew...

Read the full narrative on Cboe Global Markets (it's free!)

Cboe Global Markets is forecast to achieve $2.6 billion in revenue and $1.1 billion in earnings by 2028, reflecting a 16.9% annual decline in revenue but an increase in earnings from $896.3 million today, a value change of $203.7 million.

Uncover how Cboe Global Markets' forecasts yield a $247.47 fair value, a 3% upside to its current price.

Exploring Other PerspectivesCBOE Community Fair Values as at Oct 2025

Ten fair value estimates from the Simply Wall St Community range from US$41.96 to US$247.47 per share, highlighting a broad spectrum of expectations. This diversity of opinion sets the stage for ongoing debate about the importance of international expansion versus reliance on the S&P index options relationship.

Story Continues

Explore 10 other fair value estimates on Cboe Global Markets - why the stock might be worth as much as $247.47!

Build Your Own Cboe Global Markets Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

A great starting point for your Cboe Global Markets research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision. Our free Cboe Global Markets research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cboe Global Markets' overall financial health at a glance.

Curious About Other Options?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

Find companies with promising cash flow potential yet trading below their fair value. Uncover the next big thing with financially sound penny stocks that balance risk and reward. AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include CBOE.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments